Abstract Patients' perceptions of inconclusive results have been previously investigated in cancer genetics. The differences in how patients recall and interpret an uninformative test result compared to a known pathogenic result can affect medical decisions post disclosure. However, there is little to no data available on patients' interpretation and perception of uninformative genetic results in inherited heart disease. We report the results of a qualitative analysis of 16 telephone interviews with participants who received a negative or a variant of unknown significance (VUS) result from Long QT syndrome (LQTS) genetic testing. Our results suggest that the type of result (negative versus VUS) does not affect recall, regardless of the reason for testing. When receiving a negative result, a majority of participants appropriately perceived no change in their diagnosis, while the perception of risk for family members varied. The majority of participants felt they maintained an awareness of their condition after the result disclosure, and that clinical follow-up was similar to that planned prior to the genetic test result. Further work is needed to determine if there are any differences between obtaining a VUS result versus a negative result in this population.
Introduction
Long QT syndrome (LQTS) is an inherited cardiac arrhythmia characterized by a prolonged QT interval assessed on electrocardiogram (ECG), and can result in fainting spells (syncope), or sudden death. LQTS causes 3000-4000 sudden deaths per year in the United States, primarily in physically active young individuals (Morita et al. 2008 ). There are multiple subtypes of LQTS, each showing variable clinical expression and incomplete penetrance (Morita et al. 2008) . Almost half of patients with a known LQTS mutation may have a QT interval within the normal range and never show signs or symptoms throughout their life (Gollob 2011) . Conversely, patients may have a pathologically elongated QT interval without any currently detectable mutation. This condition has a 1/2500 population frequency in Caucasians (Schwartz et al. 2009 ), and genetic testing (sequencing and deletion/duplication) has a greater than 80 % detection rate in individuals with a clear clinical diagnosis (Aatre and Day 2011) . Patients with a clinical diagnosis may pursue genetic counseling services to discuss molecular testing options, the medical implications of the condition, and potential for cascade screening of family members.
The detection of a causative mutation allows for a molecular diagnosis and appropriate tailoring of medical management of the affected individual. In addition, it can identify family members at risk through cascade screening. Genetic based cascade screening is not always an option since it is possible to have an uninformative result when testing the proband. This presents a challenge when counseling patients with a negative result or VUS (variant of unknown significance) as these patients and their first degree relatives are still recommended to undergo Electronic supplementary material The online version of this article (doi:10.1007/s10897-016-9991-4) contains supplementary material, which is available to authorized users. LQTS screening. In this situation of an established clinical diagnosis, such as clear LQTS, both negative and VUS results are uninformative, as our current understanding of genetics does not allow us to say definitively that a negative result means there is definitely no genetic cause, nor can we state whether a VUS is in fact causative or benign. In other situations, such as genetic testing undertaken to seek or establish a diagnosis of a medical condition, a suspicious-looking VUS in a gene with a close and specific genotype-phenotype match could be considered positive evidence in favour of a diagnosis, and therefore Binformative^. Patient expectations of receiving a definitive result can lead to confusion about the implications of their genetic test result for their family members when a clearly pathogenic mutation is not identified (Hannien et al. 2014) . Learning that a test result is Bnegative^may create uncertainty in the patient's mind about the genetic basis of the condition, or even the condition itself.
One key difference between a negative result and a VUS is that there is still a variant being reported with the latter -it is our understanding of the specific variant that causes the uncertainty. The fact that there was something found on a test may influence patient perceptions differently than that of a negative result with no mutation found. The counseling around both types of results would nonetheless contain similarities about the need to wait for further advances in medical science to allow either reinterpretation or further testing and the need to continue family screening. The onus may be placed on the patient to re-contact the genetics clinic to assess if the knowledge is changed or a clinic may plan follow-up specifically to re-assess molecular testing. Awareness of possible patient perceptions will allow genetic counselors to address these lines of reasoning during pre-test counseling and follow-up care.
Patient perspectives regarding VUS have been investigated in cancer genetics, particularly interpretation of variants in the BRCA1/2 genes. Vos et al. (2008) identified differences in how patients recall a variant result and interpret the significance of these results, which in turn affects their decisions on how to pursue treatment. The potential for uninformative results through genetic testing has been identified as a barrier for patients considering genetic testing in hypertrophic cardiomyopathy and LQTS (Smart 2010) . Little to no data are available on patients' interpretation of uninformative (both negative and VUS) genetic results in inherited heart disease Vos et al. (2008) . However, there may be similarities in how patients respond to uninformative results in both conditions, as these results influence patient screening, invasive treatment options depending on genetic subtype and related magnitude of risk, and family screening.
Purpose of the Study
Despite a recognized need for better understanding of patients' reactions and interpretations of inconclusive results (Aatre and Day 2011) , our review of the literature did not identify any further published research in this area. Through semi-structured interviews, we qualitatively explored how receiving a VUS or a negative result for LQTS genetic testing affects patient recall, perception, and interpretation of results, to allow for exploration of these study questions with participants. In addition, we looked for a relationship between testing circumstances, patient recall, and interpretation of uninformative results. Conclusions from this study may inform genetic counselors about aspects of communicating an uncertain result to an at-risk LQTS patient that may need reinforcement.
Methods Participants
Patients who had previously undergone genetic testing through the BC Provincial Medical Genetics Program (PMGP) and British Columbia Inherited Arrhythmia Program (BCIAP) following a clinical diagnosis of LQTS, and subsequently received a negative or VUS genetic testing result, were considered for recruitment for the study. In addition, patients who were seen by the Department of Medical Genetics (DMG) in Victoria, British Columbia for a clinical diagnosis of LQTS and received a VUS genetic result were invited to participate. All patients received professional genetic counseling in PMGP, BCIAP or DMG during the period 2008 through 2013. Patients aged over 18 years, who could speak English and had no significant hearing impairment were eligible. Furthermore, potential participants were vetted for appropriateness of re-contact by an involved clinician, or via a form completed by some clinic patients indicating interest in research. Patients had been identified to have LQTS by their cardiologist and/or electrophysiologist. Potential study participants were recruited by a mailed letter of invitation and consent form to their home address. Following the return of written consent, interviews were scheduled. Approval of this study protocol was granted by the University of British Columbia Children's and Women's Research Ethics Board and Health Research Ethics Board (HREB) of Island Health (#H14-00,321).
Data Collection
Semi-structured, telephone interviews were conducted with participants to collect descriptive information concerning: family history of sudden death and syncope; if the participant has children; and clinical circumstances of her or his diagnosis. Interviews ranged from 6 to 21 min in length (median = 10 min). The first author (SP) conducted all interviews. Study participants were assigned a unique study ID to maintain their anonymity. Interviews were recorded and transcribed verbatim. Demographic information was collected, together with qualitative data on the level of understanding, perceptions and interpretation of the genetic testing results. Open-ended questions were designed to understand participants' experiences, perceptions and reactions to an inconclusive genetic testing result for themselves and their families. See the Appendix in Supplementary Materials for questions from the interview guide.
Data Analysis
Interviews were analysed according to grounded theory methods (McAllister 2001) , with constant comparison of data from participants. This coding began with a Bline-by-line^analysis, by which discreet ideas were given a specific label. All coding was performed by SP and JH. Any discrepancies in coding were discussed and resolved between SP and JH. Through the comparison, similar codes from each interview were grouped together to form categories, or themes and sub-themes.
Results

Participant Characteristics
Twenty-nine patients were asked to participate in the study, two (7 %) of whom were from DMG. A total of 16 participants partook in this study. The majority of those interviewed were female (n = 13, 81 %), with an overall mean age of 50 (range 21-81 years). The majority of participants were married (n = 12, 75 %). Additionally, a majority of the participants did not have a family history of LQTS (n = 12, 75 %). The largest proportion of participants had children (n = 10, 63 %). Thirteen (81 %) of the participants received a negative genetic testing result, and three received a variant of unknown significance (VUS) ( Table 1) .
Interview Findings
Emerged themes and illustrative quotes from the interview data are provided in Tables 2-9. The details are described as follows.
Negative Results Interviews (n = 13)
Reasoning behind their Decision to Pursue Genetic Testing Six participants expressed that they pursued genetic testing on a physician's recommendation following their clinical diagnosis. Four participants pursued genetic testing out of concern for their family members, so that cascade screening might become available to them. Four participants also expressed that they wished to learn more information about their diagnosis, including the type of LQTS, in case the genetic testing result would influence their treatment. Two participants articulated that they wished to aid LQTS research through their genetic testing ( Table 2) .
Circumstance of their Clinical LQTS Diagnosis Three participants were diagnosed with LQTS as an incidental finding during other investigations. Four participants had a cardiac arrest or serious cardiac event. Four participants reported a family history of LQTS, sudden death, or syncope. Three participants reported associated symptoms of LQTS leading up to their diagnosis, including syncope and shortness of breath. One participant could not recall the circumstances around their diagnosis ( Table 2) .
Perception of a Negative Result for Self Seven participants reflected that the negative genetic testing result did not change their personal perception of their LQTS diagnosis. Three participants felt that receiving a negative genetic testing result led to them questioning their clinical diagnosis. Two participants expressed a positive perception of a negative genetic result. Four participants reported negative perceptions surrounding their negative genetic testing result, including feelings of disappointment and isolation (Table 3) .
Perception of a Negative Result for Family Four participants expressed an accurate perception of what a negative result would mean for their family members. Seven participants expressed inaccurate perceptions of the negative result for their family. This includes four participants who felt relief their family were not at risk, and three who felt there was no influence on their family members' care (Table 3) .
Reaction to Result in Medical Management
Seven participants felt that there was no change to their medical management because of their genetic testing result. Four participants felt there was some change in their clinical care after receiving a negative result, either with respect to medications or additional testing and screening (Table 4) .
Reaction to Result in Personal and Lifestyle Changes
Five participants felt that the negative result let them maintain an awareness of LQTS in their everyday activities. Four participants felt they were actively making healthier lifestyle choices since the genetic testing. Five felt that the negative genetic test result had no influence on their personal life or lifestyle choices (Table 4) .
Ability to Recall Inconclusive Result Eleven participants recalled their result without reviewing the consultation letter, while one participant did utilize the letter during the interview. One participant could not remember their result. Nine participants felt they understood their result well after their genetic counseling result disclosure session, whereas one participant still found the result confusing (Table 5) .
Accuracy of Recollection Seven participants were accurate in their interpretation of their negative genetic testing result, as indicated by their understanding that their diagnosis of LQTS remained, or their acknowledgement of the chance for a negative result in LQTS. Four participants had an incorrect interpretation of their genetic testing result, such that their LQTS is not genetic, or the negative result calls their diagnosis into question, or an electrocardiogram (ECG) and genetic testing were the same test, or that a wrong/substandard test had been ordered. Five participants acknowledged that there is more work being done in LQTS research, and further testing may be available in the future (Table 5) . Incidental finding (n = 3) 'And my low pulse was initially discovered when I has hip arthroscopy.' (DS001)
Having associated symptoms (n = 3) 'I had been fainting without reason for a couple of years but my ECG's and everything came up normal. So I did a stress test and that's when we say that the QT was prolonged.' (DS013) Does not recall (n = 1) 'I think it was having an ECG and I can't remember when I was diagnosed.' (DS015)
VUS Interviews (n = 3)
Reasoning behind their Decision to Pursue Genetic Testing Two of three participants expressed that they pursued genetic testing on recommendations from their physician post their clinical diagnosis. The other participant pursued genetic testing out of concern for their children. One participant articulated that they wished to aid in LQTS research through their genetic testing (Table 6) .
LQTS Diagnosis Circumstance Two of three participants were diagnosed with LQTS as an incidental finding to other investigations. One participant had a cardiac arrest or serious cardiac event (Table 6 ).
Perception of a VUS Result for Self Two participants reflected that the VUS genetic testing result did not change their personal perception of their LQTS diagnosis. One participant expressed a positive perception of their VUS genetic result, in that they were content with the uncertainty. Two participants reported negative perceptions surrounding their VUS genetic testing result, including feelings of disappointment (Table 7) .
Perception of a VUS Result for Family All three of the participants expressed an accurate perception of what a VUS result would mean for their family members. They also all felt their result did not remove the option of pre-emptive action to be taken by their family members. One participant had a negative perception about the VUS result for their family, in that there was no certainty in the result, and that there could be discrimination for their family members (who would not be able access testing to rule out risk, if negative) ( Table 7) .
Reaction to Result in Medical Management
One participant felt there was no change to their medical management based No influence in family care (n = 3) '[…] really it didn't affect them too much because there is nothing you can really do about it.' (DS003) 'They are still trying to pretend that it doesn't affect them. ' (DS007) on their genetic testing result. Two felt there was some change in their clinical care after receiving a VUS result, either with medications or additional follow-up with the genetics clinic (Table 8 ).
Reaction to Result in Personal and Lifestyle Changes
One participant felt that the VUS result led to increased medical adherence with prescribed medication. One participant felt they were making healthier lifestyle choices since genetic testing. One felt that the VUS genetic test result had no influence on their personal life or lifestyle choices (Table 8 ).
Ability to Recall the VUS Result and Accuracy of the Recollection All participants recalled their result without referring to the consultation letter. Three participants found they understood the results following their genetic counseling result disclosure session. All had a correct interpretation of their VUS genetic testing result, expressed either as understanding that their diagnosis of LQTS remained or acknowledgement that their variant was not classified as a definite cause for the LQTS. All acknowledged that research into the causes of LQTS is ongoing, and definitive classification of their variant may become available in the future (Table 9 ).
Discussion
We assessed 16 patients' perceptions, reactions, and recall of an inconclusive genetic testing result for LQTS post a clinical diagnosis. Findings from this study may be used to inform genetic counseling sessions in which inconclusive results are being disclosed to individuals with established clinical diagnoses. In addition to the option for familial cascade genotyping, genetic testing for cardiac arrhythmias have been utilized to guide management decisions for both the patient and their family members, as certain genotypes of LQTS can indicate the use of specific medications or screening methods (Tzou and Gerstenfeld 2009) .
Half of the participants with a negative genetic result had an inaccurate perception of what the genetic testing result meant for their family members. The major misperception was that family members of an individual with a negative genetic testing result did not need cardiac screening for LQTS. This perception also has been observed in other studies of genotype-negative individuals of LQTS, in which uptake of cardiac screening in family members was reduced compared to families with a genotypepositive proband (Hannien et al. 2014 ). This effect was not mirrored by the participants with a VUS genetic result (although Table 4 Reaction to the result of medical management and to lifestyle among persons with a negative Long QT syndrome genetic result (n = 13) 'So, I am taking some of the weird precautions that, you know, I probably should be taking because of my age, but I wasn't.' (DS008) 'I had to watch how much I was exercising, more than before.' (DS013) n the number of comments made by participants our sample size, n = 3, was too small to draw firm conclusions about thematic differences); this effect which may reflect a perceived continued relationship with genetics, either through specific follow-up to revisit variant classification, or through efforts to establish evidence of co-segregation in some cases. The genetic counselling for a VUS may differ in significant ways from counselling for a negative result. The impression that
Bsomething was found^with a VUS result could factor into patients' recall and interpretation of the result. About half of participants reported that their perception of their clinical diagnosis was not altered by their genetic testing result. Perception of the genetic testing result for both the participants themselves, and their families, did not appear to be associated with a particular circumstance around diagnosis. 'So, the genetic testing was important to me because I want to find out what happened so that we can look after the boys.' (DS016) Aid with Long QT research (n = 1) '[…] I want to be able to contribute something to help learn […] if I can help contribute in some way to the knowledge base to help other people in the future.' (DS016) Diagnosis circumstance Unexpected findings (n = 2) 'I had been complaining of fatigue and low energy and that stuff for a long time and then my GP eventually sent me to an internist, where he ordered some tests for my lungs and heart.' (DS011) Cardiac event (n = 1) '[…] after the cardiac arrest, like when all the bad stuff was still happening, I exhibited signs of a prolonged QT interval.' (DS016) No certainty in genetic result (n = 1) 'So, it's a bit more stressful and heavy on her that there wasn't a definitive diagnosis.' (DS016)
Result was discriminating (n = 1) '[My sibling's employers] did not understand what the cardiac arrest was for me, and why you know, genetics investigation was going on, and that was to them, that meant my [sibling] had it for sure. ' (DS016) Both individuals in the group who were identified with LQTS post cardiac arrest and those incidentally diagnosed noted the result led to either questioning of the diagnosis for themselves or it did not change their own perception of their diagnosis. As well, the perception around risks and indicated screening for family members did not seem to differ depending on detection means or circumstance. Depending on participants' reason for testing and their understanding of the result, there appeared to be three main reactions to an inconclusive result: disappointment, questioning, and relief. Participants (both in the VUS and negative groups) whom originally wished to obtain more information around their diagnosis, and allow for genetic screening for family members, expressed disappointment in the result, as it did not fulfil these original hopes. Certain participants questioned the accuracy of their clinical diagnosis of LQTS after receipt of a negative result, and they wondered if there were other causes, such as medications, for their long QT interval. This might correspond with a belief that the genetic testing was being pursued to prove the diagnosis, and therefore the negative result indicated that they may not have LQTS. Another group of participants expressed relief in the result, as they felt that the negative result corresponded with the condition not being genetic, or that it was a less-serious variation of LQTS. This sense of relief was for their family members, as they would not be at risk of inheriting the condition, or if they were, it would not be as serious as other forms of LQTS. Our findings align with other studies showing that expectation of a definitive result can lead to confusion (questioning) when receiving a surprising result (Hannien et al. 2014) .
It is important to note that the inaccurate perceptions, interpretations of meaning, and inaccurate recollection of results do not apply to the individuals whom received a VUS result (although our sample number was small). We hypothesize this could be due to a more detailed counseling session around their particular result, or possibly increased involvement with clinical genetics. However, the three VUS result participants also had post-secondary education, two of which were in the sciences, which may have influenced their base-line genetics knowledge.
Through our interviews, it was found that only one participant reported being unclear about their result following their genetic counseling session. However, a number of individuals presented inaccurate information around their result. These concepts ranged from interpretation of the result for the diagnosis, an understanding that the diagnosis was not hereditary, that the electrocardiogram (ECG) and the genetic testing were in fact the same test, or that the test did not cover all that needed to be tested. These discrepancies in reported understanding of the testing results, and inaccurate interpretations highlight topics that could be addressed explicitly in a genetic counseling session when disclosing an inconclusive result.
In comparison, studies of BRCA1/2 patient interpretations and perceptions of their uninformative result (Rao et al. 2006; van Dijk et al. 2004 ) illustrate that a majority had accurate recall of their result, as well as the implications for their family members. However, it was also noted that many interpreted a VUS result as pathogenic, illustrating some inaccurate interpretation (Vos et al. 2008) . These findings are similar to the broad findings of our study, wherein a majority of those with a negative or VUS result were able to accurately recall their result, and had accurate Increased medical adherence (n = 1) 'I take the medication based on the result of the genetic testing.' (DS011)
Making healthier lifestyle choices (n = 1) '[…] the reminder is don't drink excessively and exercise within moderation, and these are sensible things for anyone with a heart condition.' (DS016)
Result had no influence on their personal life or lifestyle choices (n = 1) 'Well, for me it's made no difference whatsoever.' (DS006) 
Study Limitations and Strengths
This study and its conclusions are limited by the small number of participants, as well as the relatively homogeneous demographics -the majority of the participants were women, white, and married with no children. A larger proportion of our cohort received a negative genetic testing result versus a VUS. More research is required to explore perceptions and interpretations of individuals with a VUS result. As well, conclusions about the results are limited by the retrospective design and lack of validated interview questions. However, no validated interview protocols or questionnaires exist to address this topic, and it was felt that the qualitative approach would allow for deeper exploration of the study questions with participants. Another limitation of our study is that we cannot know what has been discussed with these participants by their various specialists. Even though they continued to have a working diagnosis of Long QT syndrome at the time of their genetics appointments, it is possible that other specialists later questioned the diagnosis, which would certainly alter the participants' understanding of the significance of their result. No participant however, stated during their interview that their diagnosis had been taken away. Strengths of this study include the team of authors with substantial experience in the clinical practice of cardiogenetic counseling, which informed the questions being asked and understanding of the implications of the data obtained. As well, the study cohort was systematically ascertained in a provincial referral centre.
Practice Implications and Research Recommendations
If points of potential misunderstanding are specifically explored during genetic counselling sessions and then re-addressed in a letter, the patient may benefit from a deeper and more accurate understanding of the result. Asking open-ended questions around the patient's understanding may be helpful. Numerous participants mentioned that the result letter they had received from their genetic counselor was a very helpful resource. This resource can be shared with family members, or a separate letter oriented to relatives, could highlight family screening guidelines and address patient and family members' perceptions of family members' risk, especially the common misconceptions noted in our analysis. Our findings could be relevant to other conditions as well for which genetic testing is pursued ancillary to an established clinical diagnosis.
This study illustrates fundamental findings that can be expanded into future research studies. Replication of this work could be completed on larger patient populations and different demographics to generalize the knowledge in this realm. As well, longitudinal studies comparing patient's perceptions and understanding would aid in the illustration of the long term retention of results.
